A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study

被引:26
|
作者
Kapadia, Shashi N. [1 ,2 ]
Griffin, Judith L. [1 ,3 ]
Waldman, Justine [3 ]
Ziebarth, Nicolas R. [4 ]
Schackman, Bruce R. [2 ]
Behrends, Czarina N. [2 ]
机构
[1] Weill Cornell Med, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA
[3] REACH Med, Ithaca, NY USA
[4] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA
关键词
buprenorphine; harm reduction; primary care; qualitative; opioid use disorder; TREATMENT RETENTION; TREATMENT OUTCOMES; BUPRENORPHINE; PROFESSIONALS; BARRIERS;
D O I
10.1007/s11606-020-06409-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Stigma is a barrier to the uptake of buprenorphine to treat opioid use disorder. Harm reduction treatment models intend to minimize this stigma by organizing care around non-judgmental interactions with people who use drugs. There are few examples of implementing buprenorphine treatment using a harm reduction approach in a primary care setting in the USA. Methods We conducted a qualitative study by interviewing leadership, staff, and external stakeholders at Respectful, Equitable Access to Compassionate Healthcare (REACH) Medical in Ithaca, NY. REACH is a freestanding medical practice that provides buprenorphine treatment for opioid use disorder since 2018. We conducted semi-structured interviews with 17 participants with the objective of describing REACH's model of care. We selected participants based on their position at REACH or in the community. Interviews were recorded, transcribed, and analyzed for themes using content analysis, guided by the CDC Evaluation Framework. Results REACH provided buprenorphine, primary care, and mental health services in a low-threshold model. We identified three themes related to delivery of buprenorphine treatment. First, an organizational mission to provide equitable and low-stigma healthcare, which was a key to organizational identity. Second, a low-threshold buprenorphine treatment approach that was critical, but caused concern about over-prescribing and presented logistical challenges. Third, creation and retention of a harm reduction-oriented workforce by offering value-based work and by removing administrative barriers providers may face elsewhere to providing buprenorphine treatment. Conclusions A harm reduction primary care model can help reduce stigma for people who use drugs and engage in buprenorphine treatment. Further research is needed to evaluate whether this model leads to improved patient outcomes, can overcome community stakeholder concerns, and is sustainable.
引用
收藏
页码:1898 / 1905
页数:8
相关论文
共 50 条
  • [41] Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder
    Solmeyer, Anna R.
    Berger, Aaron T.
    Barton, Sean L.
    Nguyen, Benjamin
    Bart, Gavin B.
    Grahan, Brian
    Bell, Heather J.
    DeVine, Kurt M.
    Merrick, Weston
    JAMA HEALTH FORUM, 2022, 3 (11): : E224149
  • [42] Barriers to integrating the continuum of care for opioid and alcohol use disorders in primary care: A qualitative longitudinal study
    Storholm, Erik D.
    Ober, Allison J.
    Hunter, Sarah B.
    Becker, Kirsten M.
    Iyiewuare, Praise O.
    Pham, Chau
    Watkins, Katherine E.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2017, 83 : 45 - 54
  • [43] EXAMINING THE PRIMARY CARE EXPERIENCE OF PEOPLE WITH OPIOID USE DISORDER
    Incze, Michael A.
    Chen, David
    Galyean, Patrick
    Kimball, Elisabeth
    Zickmund, Susan L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (SUPPL 2) : 144 - 144
  • [44] Identification and Management of Opioid Use Disorder in Primary Care: an Update
    Joseph H. Donroe
    Elenore P. Bhatraju
    Judith I. Tsui
    E. Jennifer Edelman
    Current Psychiatry Reports, 2020, 22
  • [45] Integrating Opioid Use Disorder Treatment Into Primary Care Settings
    Austin, Elizabeth J.
    Chen, Jessica
    Briggs, Elsa S.
    Ferro, Lori
    Barry, Paul
    Heald, Ashley
    Merrill, Joseph O.
    Curran, Geoffrey M.
    Saxon, Andrew J.
    Fortney, John C.
    Ratzliff, Anna D.
    Williams, Emily C.
    JAMA NETWORK OPEN, 2023, 6 (08) : E2328627
  • [46] Medication Treatment of Adolescent Opioid Use Disorder in Primary Care
    Carney, Brittany L.
    Hadland, Scott E.
    Bagley, Sarah M.
    PEDIATRICS IN REVIEW, 2018, 39 (01) : 43 - 45
  • [47] Identification and Management of Opioid Use Disorder in Primary Care: an Update
    Donroe, Joseph H.
    Bhatraju, Elenore P.
    Tsui, Judith I.
    Edelman, E. Jennifer
    CURRENT PSYCHIATRY REPORTS, 2020, 22 (05)
  • [48] Primary Care of Opioid use Disorder: The End of "the French Model"?
    Dupouy, Julie
    Maumus-Robert, Sandy
    Mansiaux, Yohann
    Pariente, Antoine
    Lapeyre-Mestre, Maryse
    EUROPEAN ADDICTION RESEARCH, 2020, 26 (06) : 346 - 354
  • [49] Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment SettingsHarm Reduction in Outpatient Addiction Treatment
    Jessica L. Taylor
    Samantha Johnson
    Ricardo Cruz
    Jessica R. Gray
    Davida Schiff
    Sarah M. Bagley
    Journal of General Internal Medicine, 2021, 36 : 3810 - 3819
  • [50] Sustaining alcohol and opioid use disorder treatment in primary care: a mixed methods study
    Hunter, Sarah B.
    Ober, Allison J.
    McCullough, Colleen M.
    Storholm, Erik D.
    Iyiewuare, Praise O.
    Pham, Chau
    Watkins, Katherine E.
    IMPLEMENTATION SCIENCE, 2018, 13